Abstract. Binding of steroid hormones to their cognate receptors regulates the growth of most prostate and breast cancers. We hypothesized that CYP11A inhibition might halt the synthesis of all ...
1Yonsei University, College of Medicine, Seoul, Republic of Korea.
Abstract. TNG462 is a clinical-stage, MTA-cooperative PRMT5 inhibitor currently being evaluated in an ongoing phase I/II clinical trial for solid tumors with MTAP loss. Approximately 10-15% of all ...
1Laboratory of Rare Human Circulating Cells (LCCRH), University Medical Centre of Montpellier, Montpellier, France.
Cancer Res (2023) 83 (8_Supplement): LB031.
1Division of Infectious Diseases, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. 2Center for Human Immunobiology, Department of Medicine, Feinberg ...
1Department of Biological Sciences, New York City College of Technology, City University of New York, Brooklyn, New York. 2Biology and Computer PhD Programs, The CUNY Graduate Center, City University ...
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, ...
1Department of Oncology, University of Lausanne, Lausanne, Switzerland.
Institute of TCM-X/MOE Key Laboratory of Bioinformatics, Bioinformatics Division, BNRist/Department of Automation, Tsinghua University, Beijing, China.
1Department of Medical Oncology, Gustave Roussy, Villejuif, France.
1Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. 2Cancer Program, Broad Institute of Harvard and MIT, Cambridge, Massachusetts. 3Data Science ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback